Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Mapa de calor
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
H
HELX
Franklin Genomic Advancements ETF
34.4
5
USD
-1.49%
Setor:
Finanças
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-1.49%
Mudança mensal
+2.61%
Mudança em 6 meses
+1.00%
Mudança anual
+1.00%
Fechamento anterior
34.9
7
Open
34.4
5
Mínimo
34.4
5
High
34.4
5
Volume
1
Mercados
US ETFs
HELX
1S
1M
3M
6M
Ano até a data
1A
5Y
Abrir gráfico completo
Visão geral
Todos os ativos
Mapa de calor
Principais ativos
Market Value
Shares
Weight %
STOK
Stoke Therapeutics Inc
343.150 K
10.539 K
1.600%
TWST
Twist Bioscience Corporation
341.384 K
7 184.000
1.592%
Argenx SE
328.316 K
459.000
1.531%
PTCT
PTC Therapeutics, Inc.
316.941 K
4 652.000
1.478%
TVTX
Travere Therapeutics Inc
300.933 K
10.129 K
1.403%
CRL
Charles River Laboratories International, Inc.
249.262 K
1 445.000
1.162%
CRSP
CRISPR Therapeutics AG
222.199 K
4 671.000
1.036%
RGEN
Repligen Corporation
219.852 K
1 866.000
1.025%
VCYT
Veracyte Inc
218.641 K
6 788.000
1.019%
PRAX
Praxis Precision Medicines Inc
214.901 K
667.000
1.002%
GRAL
GRAIL Inc
213.852 K
4 138.000
0.997%
Sartorius AG
205.331 K
841.000
0.957%
DHR
Danaher Corporation
199.080 K
1 050.000
0.928%
TMO
Thermo Fisher Scientific Inc
192.188 K
391.000
0.896%
IQV
IQVIA Holdings Inc.
171.393 K
1 005.000
0.799%
BEAM
BEAM THERAPEUTICS INC
167.668 K
7 036.000
0.782%
JAZZ
Jazz Pharmaceuticals PLC
158.991 K
841.000
0.741%
CPRX
Catalyst Pharmaceuticals Inc.
157.845 K
6 375.000
0.736%
CDNS
Cadence Design Systems, Inc.
151.439 K
545.000
0.706%
A
Agilent Technologies Inc.
129.481 K
1 136.000
0.604%
1
2
3
Notícias
Health Care Flies High
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset